Anti-rhesus antibodies, immune thrombocytopenia, and human immunodeficiency virus treatment. 1987

P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
June 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
July 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
January 1995, Seminars in thrombosis and hemostasis,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
May 2002, Clinical and diagnostic laboratory immunology,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
May 1989, Archives of surgery (Chicago, Ill. : 1960),
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
October 1988, Surgery, gynecology & obstetrics,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
September 2001, Current opinion in hematology,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
February 1989, DICP : the annals of pharmacotherapy,
P Bierling, and G Karianakis, and N Duedari, and C Desaint, and E Oksenhendler, and B Habibi, and Y Brossard
May 1996, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!